Home This week in gene and cell therapy - 17 May 2019 Gene and cell therapy headlines 13 May - 17 May Promethera Biosciences Announces First-Dosing in Phase 2a Clinical Study Evaluating World’s First Liver Stem Cell Therapy in Late-Stage NASH Patients Clinical Trial Underway for a Natural Killer Cell Therapy SALL3 expression balance underlies lineage biases in human induced pluripotent stem cell differentiation European Commission kills billion-euro flagship concept First-line therapy with donor-derived HCMV-specific T cells reduces persistent HCMV infection by promoting antiviral immunity after allogenic stem cell transplantation